---
layout: post
title: "General Considerations for Animal Studies Intended To Evaluate Medical Devices; Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:36:03 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-06254
original_published: 2023-03-28 00:00:00 +0000
significance: 8.00
---

# General Considerations for Animal Studies Intended To Evaluate Medical Devices; Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:36 UTC
**Source:** Federal Register
**Original Published:** March 28, 2023 00:00 UTC
**Document Number:** 2023-06254

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "General Considerations for Animal Studies Intended to Evaluate Medical Devices." FDA developed this guidance document to assist medical device sponsors, testing facilities, and other persons involved in designing, conducting, and reporting the results of animal studies intended to assess the safety of medical devices to support premarket submissions. These animal studies typically provide initial evidence of device safety, which may include device performance and handling, and the biological effects when used in a living system.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/03/28/2023-06254/general-considerations-for-animal-studies-intended-to-evaluate-medical-devices-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2023-06254

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
